Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis

Persistent breathlessness >28 days after acute COVID-19 infection has been identified as a highly debilitating post-COVID symptom. However, the prevalence, risk factors, mechanisms and treatments for post-COVID breathlessness remain poorly understood. We systematically searched PubMed and Embase...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Bang, Daines, Luke, Han, Qing, Hurst, John R., Pfeffer, Paul, Shankar-Hari, Manu, Elneima, Omer, Walker, Samantha, Brown, Jeremy S., Siddiqui, Salman, Quint, Jennifer K., Brightling, Christopher E., Evans, Rachael A., Wain, Louise V., Heaney, Liam G., Sheikh, Aziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724798/
https://www.ncbi.nlm.nih.gov/pubmed/36323418
http://dx.doi.org/10.1183/16000617.0071-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724798/
https://www.ncbi.nlm.nih.gov/pubmed/36323418
http://dx.doi.org/10.1183/16000617.0071-2022

Ejemplares similares